I agree that this site is using cookies. You can find further informations here.
X
Naoe, Tomoki
351  results:
Search for persons X
?
1

Glasdegib with intensive/nonintensive chemotherapy in Japan..:

Izutsu, Koji ; Ubukawa, Kumi ; Morishita, Takanobu...
Cancer Science.  115 (2024)  4 - p. 1250-1260 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chro..:

Matsumura, Itaru ; Ohtake, Shigeki ; Atsuta, Yoshiko...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
3

Immunoreactivity to WT1 peptide vaccine is associated with ..:

Naoe, Tomoki ; Saito, Akiko ; Hosono, Nahoko...
Cancer Immunology, Immunotherapy.  72 (2023)  8 - p. 2865-2871 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Phase 1/2 study evaluating the safety and efficacy of DSP‐7..:

Ueda, Yasunori ; Usuki, Kensuke ; Fujita, Jiro...
Cancer Science.  113 (2022)  4 - p. 1377-1392 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Clinical outcomes of second‐generation tyrosine kinase inhi..:

Ono, Takaaki ; Takahashi, Naoto ; Kizaki, Masahiro...
Cancer Science.  114 (2022)  3 - p. 995-1006 , 2022
Link: https://doi.org/10.1111/..
 
?
6

A phase II randomized study evaluating azacitidine versus c..:

Iida, Hiroatsu ; Imada, Kazunori ; Ueda, Yasunori...
International Journal of Hematology.  115 (2022)  5 - p. 694-703 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Prospective comparison of 5- and 7-day administration of az..:

Miyazaki, Yasushi ; Kiguchi, Toru ; Sato, Shinya...
International Journal of Hematology.  116 (2022)  2 - p. 228-238 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Phase 3 trial of gilteritinib plus azacitidine vs azacitidi..:

Wang, Eunice S. ; Montesinos, Pau ; Minden, Mark D....
Blood.  140 (2022)  17 - p. 1845-1857 , 2022
Link: https://doi.org/10.1182/..
 
?
9

Adjunctive Volasertib in Patients With Acute Myeloid Leukem..:

Döhner, Hartmut ; Symeonidis, Argiris ; Deeren, Dries...
HemaSphere.  5 (2021)  8 - p. e617 , 2021
Link: https://doi.org/10.1097/..
 
?
10

Gilteritinib versus chemotherapy in Japanese patients with ..:

Hosono, Naoko ; Yokoyama, Hisayuki ; Aotsuka, Nobuyuki...
International Journal of Clinical Oncology.  26 (2021)  11 - p. 2131-2141 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Efficacy and safety of Wilms' tumor 1 helper peptide OCV-50..:

Kiguchi, Toru ; Yamaguchi, Masaki ; Takezako, Naoki...
Cancer Immunology, Immunotherapy.  71 (2021)  6 - p. 1419-1430 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Treatment outcomes of chronic-phase chronic myeloid leukemi..:

the New TARGET investigators ; Sakurai, Masatoshi ; Okamoto, Shinichiro...
International Journal of Hematology.  111 (2020)  6 - p. 812-825 , 2020
Link: https://doi.org/10.1007/..
 
?
13

In vivo tracking of transplanted macrophages with near infr..:

Nishiwaki, Satoshi ; Saito, Shigeki ; Takeshita, Kyosuke...
PLOS ONE.  15 (2020)  12 - p. e0242488 , 2020
Link: https://doi.org/10.1371/..
 
?
14

Allogeneic hematopoietic stem cell transplantation at the f..:

Kawashima, Naomi ; Ishikawa, Yuichi ; Atsuta, Yoshiko...
Cancer Science.  111 (2020)  7 - p. 2472-2481 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Impact of CD56 Continuously Recognizable as Prognostic Valu..:

Takeshita, Akihiro ; Asou, Norio ; Atsuta, Yoshiko...
Cancers.  12 (2020)  6 - p. 1444 , 2020
Link: https://doi.org/10.3390/..
 
1-15